Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis

Gut

Volumn 40, Issue 1, 1997, Pages 80-85

  Messmann, H ^a   Vogt, W ^a   Holstege, A ^a   Lock, G ^a   Heinisch, A ^a   Von Furstenberg A ^a   Leser, H G ^a   Zirngibl, H ^a   Scholmerich J ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

C reactive protein; Cytokines; Interleukin 6; Pancreatitis; Tumour necrosis factor

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; TUMOR NECROSIS FACTOR;

ACUTE PANCREATITIS; ACUTE PHASE RESPONSE; ARTICLE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MODEL; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 0031050280     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.1.80     Document Type: Article

References (26)

1. Pitchumoni CS, Agarwal N, Jain NK. Systemic complications of acute pancreatitis. Am J Gastroenterol 1988; 83: 597-606.
2. Schölmerich J, Heinisch A, Leser HG. Diagnostic approach to acute pancreatitis: diagnosis, assessment of etiology and prognosis. Hepatogastroenterol 1993; 40: 531-7.
3. Ranson JHC, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974; 139: 69-80.
4. Groß V, Schölmerich J, Leser HG, Salm R, Lausen M, Rückauer K, et al. Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute- phase proteins C-reactive protein, α1-antitrypsin and protease inhibitor α2-macroglobulin. Dig Dis Sci 1990; 35: 97-105.
5. Uhl W, Büchler M, Malfertheiner P, Beger H. PMN- elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991; 6: 253-9.
6. MacMahon M, Bowen M, Mayer A, Cooper E. Relation of α2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis. Am J Surg 1984; 147: 164-70.
7. Mayer AD, McMahon MJ, Bowen M, Cooper EH. C reactive protein: an aid to assessment and monitoring of acute pancreatitis. J Clin Pathol 1984; 37: 207-11.
8. Puolakkainen P, Valtonen V, Paanen A, Schröder T. C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut 1987; 28: 764-71.
9. Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989; 76: 177-81.
10. Leser H-G, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, et al. Elevation of interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991; 101: 782-5.
11. Viedma JA, Pérez-Mateo M, Dominguez JE, Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reacrive protein and phospholipase A. Gut 1992; 33: 1264-7.
12. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34: 41-5.
13. Skude G, Whelin L, Maruyama T, Aryiama J. Hyperamylasaemia after duodenoscopy and retrograde cholangiography. Gut 1977; 18: 316-41.
14. Panthegini M, Pagani F, Alebradi O, Lancini G, Cestari R. Time course of changes in pancreatic enzymes, isoenzymes and isoforms in serum after endoscopic retrograde cholangiopancreaticography. Clin Chem 1991; 37: 1602-5.
15. Nemesánsky E, Tulassay Z, Papp J. Serum enzyme changes after endoscopic retrograde cholangio-pancreaticography/ERCP/. Acta Hepato-astroenterolegica 1978; 23: 228-32.
16. Fjøsne U, Waldum HL, Romslo L, Kleveland PM, Johnsen H, Engerbretsen LF. Amylase, pancreatic isoamylase and lipase in serum before and after endoscopic pancreatography. Acta Med Scand 1986; 219: 301-4.
17. LaFerla G, Gordon S, Archibals M, Murray WR. Hyperamylasaemia and acute pancreatitis following endoscopic retrograde cholangiography. Pancreas 1985; 1: 160-3.
18. Sherman S, Lehman GA. ERCP- and endoscopic sphincterotomy-induced pancreatitis. Pancreas 1991; 6: 350-67.
19. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 1988; 3: 105-12.
20. Weiner GR, Geenen JE, Hogan WJ, Catalano MF. Use of corticosteroids in the prevention of post-ERP- pancreatitis. Gastrointest Endosc 1995; 42: 579-83.
21. Nishimito N, Yoshizaki K, Tagoh H, Monden M, Kishimoto S, Hirano T, Kishimoto T. Elevation of serum interleukin-6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunpathol 1989; 50: 399-401.
22. Cruickshank AM, Fraser WD, Burns HJG, Van Damme J, Shenkin A. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci 1990; 79: 161-5.
23. Hughes CB, Gaber LW, Kotb M, Mohey el-Din AB, Pabst M, Gaber O. Induction of acute pancreatitis in germ-free rats: Evidence of a primary role for tumor necrosis factor alpha. Surgery 1995; 117: 201-3.
24. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe pancreatitis. Gut 1992; 33: 1126-8.
25. Paajanen H, Laato M, Jaakkola M, Pulkki K, Niinikoski J, Nordback I. Serum tumour necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis. Br J Surg 1995; 82: 271-3.
26. Norman JG, Fink GW, Franz MG. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995; 130: 966-70.